About: Aminopeptidase N (APN; EC 3.4.11.2) purified from Escherichia coli has been crystallized with the optically pure aminophosphinic inhibitor PL250, H(3)N(+)‐CH(CH(3))‐P(O)(OH)‐CH(2)‐CH(CH(2)Ph)‐CONH‐CH(CH(2)Ph)CO(2) (−), which mimics the transition state of the hydrolysis reaction. PL250 inhibits APN with a K (i) of 1.5–2.2 nM and its three‐dimensional structure in complex with E. coli APN showed its interaction with the S(1), S′(1) and S′(2) subsites of the catalytic site. In this structure, the Zn ion was shown to be pentacoordinated by His297, His301 and Glu320 of APN and the two O atoms of the phosphinic moiety of PL250. One of these O atoms is also involved in a hydrogen bond to Tyr381, supporting the proposed role of this amino acid in the stabilization of the transition state of the enzymatic process. The strength of the phosphinic zinc binding and the occupancy of the S′(2) subsite account for the 100‐fold increase in affinity of PL250 compared with the dipeptide‐derived inhibitor bestatin (K (i) = 4.1 × 10(−6) M). Accordingly, the removal of the C‐terminal phenylalanine of PL250 resulted in a large decrease in affinity (K (i) = 2.17 × 10(−7) M). Furthermore, it was observed that the C‐terminal carboxyl group of the inhibitor makes no direct interactions with the amino acids of the APN active site. Interestingly, PL250 exhibits the same inhibitory potency for E. coli APN and for mammalian enzymes, suggesting that the structure of the complex could be used as a template for the rational design of various human APN inhibitors needed to study the role of this aminopeptidase in various pathologies.   Goto Sponge  NotDistinct  Permalink

An Entity of Type : fabio:Abstract, within Data Space : covidontheweb.inria.fr associated with source document(s)

AttributesValues
type
value
  • Aminopeptidase N (APN; EC 3.4.11.2) purified from Escherichia coli has been crystallized with the optically pure aminophosphinic inhibitor PL250, H(3)N(+)‐CH(CH(3))‐P(O)(OH)‐CH(2)‐CH(CH(2)Ph)‐CONH‐CH(CH(2)Ph)CO(2) (−), which mimics the transition state of the hydrolysis reaction. PL250 inhibits APN with a K (i) of 1.5–2.2 nM and its three‐dimensional structure in complex with E. coli APN showed its interaction with the S(1), S′(1) and S′(2) subsites of the catalytic site. In this structure, the Zn ion was shown to be pentacoordinated by His297, His301 and Glu320 of APN and the two O atoms of the phosphinic moiety of PL250. One of these O atoms is also involved in a hydrogen bond to Tyr381, supporting the proposed role of this amino acid in the stabilization of the transition state of the enzymatic process. The strength of the phosphinic zinc binding and the occupancy of the S′(2) subsite account for the 100‐fold increase in affinity of PL250 compared with the dipeptide‐derived inhibitor bestatin (K (i) = 4.1 × 10(−6) M). Accordingly, the removal of the C‐terminal phenylalanine of PL250 resulted in a large decrease in affinity (K (i) = 2.17 × 10(−7) M). Furthermore, it was observed that the C‐terminal carboxyl group of the inhibitor makes no direct interactions with the amino acids of the APN active site. Interestingly, PL250 exhibits the same inhibitory potency for E. coli APN and for mammalian enzymes, suggesting that the structure of the complex could be used as a template for the rational design of various human APN inhibitors needed to study the role of this aminopeptidase in various pathologies.
Subject
  • Bacteria described in 1919
  • Physical chemistry
  • Phosphorus(−3) compounds
part of
is abstract of
is hasSource of
Faceted Search & Find service v1.13.91 as of Mar 24 2020


Alternative Linked Data Documents: Sponger | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software